SIGG.F Stock Overview
Engages in the wholesale distribution of pharmaceutical goods and medical consumables to community pharmacies primarily in Australia.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 5/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Sigma Healthcare Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.87 |
| 52 Week High | AU$0.89 |
| 52 Week Low | AU$0.40 |
| Beta | 0.27 |
| 11 Month Change | 2.18% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -80.10% |
Recent News & Updates
Recent updates
Shareholder Returns
| SIGG.F | US Healthcare | US Market | |
|---|---|---|---|
| 7D | 0% | 0.3% | 0.9% |
| 1Y | n/a | 12.0% | 32.3% |
Return vs Industry: Insufficient data to determine how SIGG.F performed against the US Healthcare industry.
Return vs Market: Insufficient data to determine how SIGG.F performed against the US Market.
Price Volatility
| SIGG.F volatility | |
|---|---|
| SIGG.F Average Weekly Movement | n/a |
| Healthcare Industry Average Movement | 7.0% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in US Market | 14.8% |
| 10% least volatile stocks in US Market | 3.2% |
Stable Share Price: SIGG.F has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine SIGG.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1912 | n/a | Vikesh Ramsunder | www.sigmahealthcare.com.au |
Sigma Healthcare Limited, together with its subsidiaries, engages in the wholesale distribution of pharmaceutical goods and medical consumables to community pharmacies primarily in Australia. The company operates various aligned pharmacies, including branded pharmacies under the Amcal, Discount Drug Stores, Guardian, and PharmaSave brands. It also provides retail support services to its branded network of pharmacy members; dose administration aid services; and third and fourth-party logistics services to pharmaceutical manufacturers and other supplier partners.
Sigma Healthcare Limited Fundamentals Summary
| SIGG.F fundamental statistics | |
|---|---|
| Market cap | US$1.58b |
| Earnings (TTM) | -US$2.07m |
| Revenue (TTM) | US$2.40b |
0.7x
P/S Ratio-764.0x
P/E RatioIs SIGG.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SIGG.F income statement (TTM) | |
|---|---|
| Revenue | AU$3.48b |
| Cost of Revenue | AU$3.25b |
| Gross Profit | AU$227.84m |
| Other Expenses | AU$230.83m |
| Earnings | -AU$2.99m |
Last Reported Earnings
Jul 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.0019 |
| Gross Margin | 6.55% |
| Net Profit Margin | -0.086% |
| Debt/Equity Ratio | 0% |
How did SIGG.F perform over the long term?
See historical performance and comparison